In terms of Regulation 29 (1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that a meeting of the Board of Directors of the Company scheduled to be held on Tuesday, November 13, 2018, to consider and approve the text of Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2018. Further, in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window of the Company shall remain closed from Tuesday, November 6, 2018 to Thursday, November 15, 2018.
The above information is a part of company’s filings submitted to BSE.
